445 related articles for article (PubMed ID: 22828666)
1. Carnosic acid inhibits the growth of ER-negative human breast cancer cells and synergizes with curcumin.
Einbond LS; Wu HA; Kashiwazaki R; He K; Roller M; Su T; Wang X; Goldsberry S
Fitoterapia; 2012 Oct; 83(7):1160-8. PubMed ID: 22828666
[TBL] [Abstract][Full Text] [Related]
2. Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid.
Steiner M; Priel I; Giat J; Levy J; Sharoni Y; Danilenko M
Nutr Cancer; 2001; 41(1-2):135-44. PubMed ID: 12094616
[TBL] [Abstract][Full Text] [Related]
3. Curcumin suppresses the TPA-induced invasion through inhibition of PKCα-dependent MMP-expression in MCF-7 human breast cancer cells.
Kim JM; Noh EM; Kwon KB; Kim JS; You YO; Hwang JK; Hwang BM; Kim BS; Lee SH; Lee SJ; Jung SH; Youn HJ; Lee YR
Phytomedicine; 2012 Sep; 19(12):1085-92. PubMed ID: 22921746
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effects of curcumin on gastric cancer cells: a proteomic study of molecular targets.
Cai XZ; Huang WY; Qiao Y; Du SY; Chen Y; Chen D; Yu S; Che RC; Liu N; Jiang Y
Phytomedicine; 2013 Apr; 20(6):495-505. PubMed ID: 23351961
[TBL] [Abstract][Full Text] [Related]
5. Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin.
Sun SH; Huang HC; Huang C; Lin JK
Eur J Pharmacol; 2012 Sep; 690(1-3):22-30. PubMed ID: 22705896
[TBL] [Abstract][Full Text] [Related]
6. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription.
Liu Q; Loo WT; Sze SC; Tong Y
Phytomedicine; 2009 Oct; 16(10):916-22. PubMed ID: 19524420
[TBL] [Abstract][Full Text] [Related]
7. Anticancer activity of litchi fruit pericarp extract against human breast cancer in vitro and in vivo.
Wang X; Yuan S; Wang J; Lin P; Liu G; Lu Y; Zhang J; Wang W; Wei Y
Toxicol Appl Pharmacol; 2006 Sep; 215(2):168-78. PubMed ID: 16563451
[TBL] [Abstract][Full Text] [Related]
8. RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Sep; 41(3):1119-27. PubMed ID: 22710975
[TBL] [Abstract][Full Text] [Related]
9. Rosemary (Rosmarinus officinalis L.) Extract as a Potential Complementary Agent in Anticancer Therapy.
González-Vallinas M; Reglero G; Ramírez de Molina A
Nutr Cancer; 2015; 67(8):1221-9. PubMed ID: 26452641
[TBL] [Abstract][Full Text] [Related]
10. Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines.
Ramachandran C; Rodriguez S; Ramachandran R; Raveendran Nair PK; Fonseca H; Khatib Z; Escalon E; Melnick SJ
Anticancer Res; 2005; 25(5):3293-302. PubMed ID: 16101141
[TBL] [Abstract][Full Text] [Related]
11. Curcumin decreases acid sphingomyelinase activity in colon cancer Caco-2 cells.
Cheng Y; Kozubek A; Ohlsson L; Sternby B; Duan RD
Planta Med; 2007 Jul; 73(8):725-30. PubMed ID: 17583825
[TBL] [Abstract][Full Text] [Related]
12. Proteomic identification of differentially expressed proteins in curcumin-treated MCF-7 cells.
Fang HY; Chen SB; Guo DJ; Pan SY; Yu ZL
Phytomedicine; 2011 Jun; 18(8-9):697-703. PubMed ID: 21239154
[TBL] [Abstract][Full Text] [Related]
13. Diterpenes from rosemary (Rosmarinus officinalis): Defining their potential for anti-cancer activity.
Petiwala SM; Johnson JJ
Cancer Lett; 2015 Oct; 367(2):93-102. PubMed ID: 26170168
[TBL] [Abstract][Full Text] [Related]
14. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Nov; 41(5):1723-32. PubMed ID: 22971638
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferation effect of Rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro.
Tai J; Cheung S; Wu M; Hasman D
Phytomedicine; 2012 Mar; 19(5):436-43. PubMed ID: 22325591
[TBL] [Abstract][Full Text] [Related]
16. Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest.
Wang YT; Liu HS; Su CL
Int J Food Sci Nutr; 2014 May; 65(3):368-74. PubMed ID: 24438326
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of supercritical carbon dioxide extract and its isolated carnosic acid from Rosmarinus officinalis leaves.
Kuo CF; Su JD; Chiu CH; Peng CC; Chang CH; Sung TY; Huang SH; Lee WC; Chyau CC
J Agric Food Chem; 2011 Apr; 59(8):3674-85. PubMed ID: 21375325
[TBL] [Abstract][Full Text] [Related]
18. The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: analysis of the possible molecular basis.
Poma P; Notarbartolo M; Labbozzetta M; Maurici A; Carina V; Alaimo A; Rizzi M; Simoni D; D'Alessandro N
Int J Mol Med; 2007 Sep; 20(3):329-35. PubMed ID: 17671737
[TBL] [Abstract][Full Text] [Related]
19. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effect of an analog of curcumin bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione in human breast cancer cells.
Kumaravel M; Sankar P; Rukkumani R
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1900-7. PubMed ID: 23242714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
